Manufactured by:Dermik Laboratoriesa business of sanofi-aventis U.S.
LLCBridgewater, NJ 08807Manufactured for:Prasco LaboratoriesCincinnati, OH 45249 USARevised April 2007© 2007 sanofi-aventis U.S.
Metronidazole Cream, 1%, is indicated for the topical treatment of inflammatory lesions and erythema of rosacea.
-- Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of causes.
-- A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).
Metronidazole Cream, 1%, is contraindicated in those patients with a history of hypersensitivity to metronidazole or to any other ingredient in this formulation.
-- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor.
It should not to be used for self-diagnosis or treatment.